MILLERTON, OKLAHOMA - 01/14/2017 (PRESS RELEASE JET)
Hospitals and orthopedic surgeons can now evaluate a new treatment for spinal cord injury. Research results have demonstrated the world's first success in treating a spinal cord injury with only a topical rub-on ointment that penetrates deeply and converts normal cells into stem cells. Until recently, this kind of simple rub-it-on treatment has never before been used to transform a paraplegic into a walking, functioning person.
The treatment relies on a new formulation that creates stem cells deep below the skin using only a highly-penetrating ointment. The FDA-registered ointment is called TetraStem. TetraStem is an antibiotic normally used to treat cuts, as an on-label topical drug. But it was discovered 5 years ago that it also can induce stem-cell healing; first in an animal research program and then in human research programs. The new ointment is being developed by the world's only not-for-profit FDA-registered drug manufacturing company.
Miranda is the first patient to benefit from this simple but effective experimental treatment. Miranda's treatment and progress is reported online at www.PhillipsCompany.4T.com/Miranda.pdf
TetraStem is being developed by Phillips Company, who now offers any hospital or orthopedic surgeon the opportunity to evaluate this new drug in the treatment of spinal cord injury.
|person_outline||Full Name:||Howard Phillips, General Manager|
|phone||Phone Number:||580 746 2430|
|mail_outline||Email: Send Email|